首页> 外文期刊>World Journal of Cardiovascular Surgery >Source, Triggers and Clinical Implications of Hyperlactemia in Patients Undergoing Mitral Valve Surgery Using Custodiol Cardioplegia
【24h】

Source, Triggers and Clinical Implications of Hyperlactemia in Patients Undergoing Mitral Valve Surgery Using Custodiol Cardioplegia

机译:邻苯二甲酸二丁酯心脏停搏术进行二尖瓣手术的患者高乳酸血症的来源,诱因和临床意义

获取原文
           

摘要

Background: Postoperative blood hyperlactaemia is an indicator of organ anaerobic metabolism and is associated with morbidity after cardiac surgery. This prospective study aims to explore the source, triggers and clinical implications for hyperlactaemia in patients undergoing mitral valve surgery using Custodiol cardioplegia. Methods: Twenty consecutive elective patients undergoing open-heart surgery for mitral valve repair/replacement using Custodiol (based on Bretschneider’s HTK-solution) cardioplegia were recruited. A serial measurement of arterial blood lactate was performed. Pre-, intra-and post-operative clinical data were obtained and cardiac injury was determined by serial plasma measurement of postoperative release of CK-MB. Results: There were no in-hospital deaths. Most of the patients (n = 16) needed intraoperative direct current cardioversion to treat ventricular arrhythmias or post-operative vasopressors (n = 13) to treat vasoplegia. There was significant cardiac injury as determined by the marked increase of serum CK-MB (p 0.05). A significant (p 0.05) increase in blood lactate was found to follow a biphasic profile. The first peak (from 0.54 ± 0.03 to 1.3 ± 0.07 mM) was observed immediately following the release of the aortic cross-clamp and remained high for 1 hour. This was followed by a second peak at 12 hours post-operatively (1.9 ± 0.2 mM). The second rise in lactate was seen only in patients that required post-operative vasopressors (1.3 ± 0.2 vs 2.2 ±0.3 mM, p 0.05), in whom a significant late decrease in CVP was also observed (12.2 ± 1.0 to 7.7 ± 1.0 for 1 and 12 hours postoperative, respectively). Hyperlactaemia did not correlate with any other variables including CK-MB levels, cross-clamp or cardiopulmonary bypass time. Conclusions: In patients undergoing mitral valve surgery with Custodiol cardioplegia there is marked cardiac injury and a biphasic release of blood lactate. The initial peak in lactate occurs immediately following unclamping the aorta and is likely to be of organ (e.g. heart and lungs) origin. A second peak is only seen in patients requiring postoperative vasopressors to treat vasoplegia. Hyperlactaemia following mitral valve surgery with Custodiol cardioplegia does not seem to be related to myocardial injury as expressed by CK-MB release.
机译:背景:术后血液过高血症是器官无氧代谢的指标,与心脏手术后的发病率有关。这项前瞻性研究旨在探讨使用二邻苯二甲酸二丁酯心脏麻痹进行二尖瓣手术的患者高泌乳血症的来源,诱因和临床意义。方法:招募了20名连续接受择期手术的患者,这些患者接受了使用Custodiol(基于Bretschneider的HTK溶液)进行的二尖瓣修复/置换的心脏直视手术。进行了动脉血乳酸的系列测量。获得了术前,术中和术后的临床数据,并通过连续血浆血浆测量CK-MB的释放来确定心脏损伤。结果:无院内死亡。大多数患者(n = 16)需要术中直流电复律来治疗室性心律不齐或术后升压药(n = 13)来治疗血管麻痹。根据血清CK-MB的显着增加确定存在严重的心脏损伤(p 0.05)。发现血乳酸显着(p 0.05)呈两相分布。在主动脉夹钳释放后立即观察到第一个峰(从0.54±0.03到1.3±0.07 mM),并保持高位1小时。术后12小时出现第二个峰值(1.9±0.2 mM)。仅在需要术后血管升压药的患者中观察到乳酸的第二次升高(1.3±0.2 vs 2.2±0.3 mM,p 0.05),其中还观察到CVP的晚期显着下降(12.2±1.0至7.7±1.0)分别是术后1小时和12小时)。高渗血症与任何其他变量均不相关,包括CK-MB水平,交叉钳夹或体外循环时间。结论:二尖瓣手术伴Custodiol心脏停搏的患者存在明显的心脏损伤和血液乳酸的双相释放。乳酸的初始峰值在松开主动脉后立即出现,并且很可能是器官(例如心脏和肺)起源的。仅在需要术后升压药治疗血管麻痹的患者中看到第二个高峰。二尖瓣手术伴有Custodiol停搏的高泌尿血症似乎与CK-MB释放所表达的心肌损伤无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号